Products for Research Use Only
RegisterLogin

RET-IN-13

CAT: 0804-HY-144029Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-144029Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
RET-IN-13 (compound 1), a quinoline compound, is a potent RET inhibitor with IC50s of 0.5 nM, 0.9 nM for RET (WT) and RET (V804M), respectively. RET-IN-13 has the potential for tumors or intestinal diseases related to abnormal activation of RET research[1].
CAS Number
2684258-54-4
UNSPSC
12352005
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-13.html
Solubility
10 mM in DMSO
Smiles
O=C(CC1=CC=C(C2=CN=C3C=C(C(OC)=CC3=C2)OC)N=C1)NC4=C(F)C=C(CN5CCN(CC5)CC)C(C(F)(F)F)=C4
Molecular Formula
C32H33F4N5O3
Molecular Weight
611.63
References & Citations
[1]Jiansong Wang, et al. Quinoline compounds. WO2021164742A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-112950RET-IN-1
HY-133553-01RET-IN-3
HY-145024RET-IN-6
HY-145023RET-IN-5
HY-178786RET-IN-31
HY-144422RET-IN-15
HY-148742-01RET-IN-21
HY-153676-01RET-IN-23
HY-147563RET-IN-17
HY-149099RET-IN-22

Alternative Products

CatalogName
GTR19212278-01RET-IN-13
R1701-17RET protein (RET)
V8277-100UGRET Antibody / c-RET
V8276-100UGC-RET Antibody / RET
030598RET (ret proto-oncogene)
332425-01Ret

Popular Products